EUVIMEDEUVIMED entdecken
Kontrollierte klinische StudieOpen Access · CC BY 4.0

House dust mite subcutaneous immunotherapy has sustained long‐term effectiveness on allergic rhinitis and asthma: A 10‐year follow‐up

Elena Rodriguez-Plata, Ariel Callero Viera iD, Monica Ruiz-Garcia iD, Aida Gomez-Cardenosa, Eva Nieto, Jose Carlos García-Robaina

Immunity, Inflammation and Disease · 2023-10 · 11 (10)

DOI: 10.1002/iid3.1004 ↗

Kurz gefasst

Kontrollierte klinische Studie in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 13.10.2023. Verfasst von Elena Rodriguez-Plata und 5 weiteren Autor:innen. Beteiligte Einrichtung: Allergy Department, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain. Hauptthemen laut MEDLINE: Asthma, Rhinitis, Allergic. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Maintenance doses for allergen immunotherapy (AIT) have been recommended for at least 3 years but little data on long‐term efficacy is available depending on AIT duration. To show sustained efficacy 10 years after completion of treatment with depigmented‐polymerized house dust mite (dpg‐pol HDM) allergen extract in adults with asthma and/or rhinoconjunctivitis.

Methods

Patients included in a double‐blind placebo‐controlled AIT study with dpg‐pol HDM allergen extract were reviewed at completion of the perennial treatment and 10‐year follow‐up (10y‐FU). Change in symptom and rescue medication score was the primary objective. Visual analog scale (VAS), asthma control test (ACT), and degree of disease control were the secondary objectives. A comparative analysis between patients who underwent AIT treatment for

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaRhinitis, AllergicAdultAnimalsHumansAllergensDermatophagoides pteronyssinusDesensitization, ImmunologicFollow-Up StudiesPyroglyphidaeDouble-Blind Method

Stichwörter der Autor:innen

allergic asthmaallergic rhinitishouse dust mitelong-term effectivenesssubcutaneous immunotherapy

Substanzen

Allergens

Autor:innen und Institutionen

  • Allergy Department, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
  • Medical Affairs and Clinical Department, LETI Pharma, Madrid, Spain.

ORCID-Profile: Ariel Callero Viera, Monica Ruiz-Garcia

Zitieren

APA

Rodriguez-Plata, E., Callero Viera, A., Ruiz-Garcia, M., Gomez-Cardenosa, A., Nieto, E., & García-Robaina, J. C. (2023). House dust mite subcutaneous immunotherapy has sustained long‐term effectiveness on allergic rhinitis and asthma: A 10‐year follow‐up. Immunity, Inflammation and Disease, 11(10). https://doi.org/10.1002/iid3.1004

Vancouver

Rodriguez-Plata E, Callero Viera A, Ruiz-Garcia M, Gomez-Cardenosa A, Nieto E, García-Robaina JC. House dust mite subcutaneous immunotherapy has sustained long‐term effectiveness on allergic rhinitis and asthma: A 10‐year follow‐up. Immunity, Inflammation and Disease. 2023;11(10). doi:10.1002/iid3.1004

BibTeX
@article{RodriguezPlata2023,
  author = {Rodriguez-Plata, Elena and Callero Viera, Ariel and Ruiz-Garcia, Monica and Gomez-Cardenosa, Aida and Nieto, Eva and García-Robaina, Jose Carlos},
  title = {House dust mite subcutaneous immunotherapy has sustained long‐term effectiveness on allergic rhinitis and asthma: A 10‐year follow‐up},
  journal = {Immunity, Inflammation and Disease},
  year = {2023},
  volume = {11},
  number = {10},
  doi = {10.1002/iid3.1004}
}
Kostenlos starten →